This company may still be operating, however this listing is no longer active. Find out why through their latest events.

G1 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:G1H Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
05 Jul 24	Sell€1,221	John Umstead	Individual	527	€2.32
05 Jul 24	Sell€5,733	Rajesh Malik	Individual	2,475	€2.32
05 Jul 24	Sell€5,733	Terry Murdock	Individual	2,475	€2.32
05 Jul 24	Sell€17,748	John Bailey	Individual	7,662	€2.32
05 Jul 24	Sell€6,111	Mark Avagliano	Individual	2,638	€2.32
05 Jul 24	Sell€3,097	Andrew Perry	Individual	1,337	€2.32
23 May 24	Sell€22,972	Monica Thomas	Individual	5,826	€3.94
13 May 24	Sell€165,307	John Bailey	Individual	37,258	€4.44
13 May 24	Sell€36,165	Terry Murdock	Individual	8,151	€4.44
13 May 24	Sell€36,165	John Umstead	Individual	8,151	€4.44
13 May 24	Sell€36,165	Andrew Perry	Individual	8,151	€4.44
13 May 24	Sell€36,165	Mark Avagliano	Individual	8,151	€4.44
13 May 24	Sell€36,165	Rajesh Malik	Individual	8,151	€4.44
18 Mar 24	Sell€18,168	John Umstead	Individual	6,547	€2.77
04 Jan 24	Sell€298	John Umstead	Individual	111	€2.68
04 Jan 24	Sell€1,936	Terry Murdock	Individual	721	€2.68
04 Jan 24	Sell€1,936	Mark Avagliano	Individual	721	€2.68
04 Jan 24	Sell€1,936	Rajesh Malik	Individual	721	€2.68
03 Jan 24	Sell€33,393	John Bailey	Individual	11,686	€2.86
03 Jan 24	Sell€1,806	John Umstead	Individual	632	€2.86
03 Jan 24	Sell€8,627	Terry Murdock	Individual	3,019	€2.86
03 Jan 24	Sell€9,601	Mark Avagliano	Individual	3,360	€2.86
03 Jan 24	Sell€6,895	Andrew Perry	Individual	2,413	€2.86
03 Jan 24	Sell€8,627	Rajesh Malik	Individual	3,019	€2.86
02 Jan 24	Sell€98,545	John Bailey	Individual	32,983	€2.99

Insider Buying: G1H insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.2%.

Top 25 shareholders own 56.42% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.79%	Beryl Capital Management LLC	5,179,529	€33.3m	0%	7.87%
7.97%	Eshelman Ventures, LLC	4,216,074	€27.1m	0%	100.0%
5.83%	BlackRock, Inc.	3,082,031	€19.8m	359%	no data
5.58%	MedImmune Ventures, Inc.	2,950,630	€19.0m	0%	100.0%
4.71%	The Vanguard Group, Inc.	2,491,109	€16.0m	19.7%	no data
2.58%	Woodline Partners LP	1,362,354	€8.8m	0%	0.09%
2.35%	Renaissance Technologies LLC	1,245,180	€8.0m	37.8%	0.01%
2.04%	Geode Capital Management, LLC	1,079,645	€6.9m	113%	no data
1.75%	Acadian Asset Management LLC	928,205	€6.0m	114%	0.02%
1.57%	State Street Global Advisors, Inc.	827,956	€5.3m	414%	no data
1.51%	Qube Research & Technologies Ltd	800,511	€5.1m	147%	0.01%
1.51%	Raymond James Financial Inc., Asset Management Arm	797,677	€5.1m	-0.64%	no data
1.45%	D. E. Shaw & Co., L.P.	767,066	€4.9m	-2.32%	0.01%
1.09%	Connor, Clark & Lunn Investment Management Ltd.	576,354	€3.7m	39.4%	0.02%
1.04%	Fredric Eshelman	550,000	€3.5m	0%	no data
0.88%	Jacobs Levy Equity Management Inc	463,593	€3.0m	22.7%	0.01%
0.8%	abrdn plc	423,869	€2.7m	0%	no data
0.75%	Bridgeway Capital Management, LLC	398,043	€2.6m	108%	0.05%
0.74%	Morgan Stanley, Investment Banking and Brokerage Investments	392,184	€2.5m	124%	no data
0.58%	Two Sigma Investments, LP	308,825	€2.0m	-7.57%	0.01%
0.4%	Two Sigma Advisers, LP	211,700	€1.4m	15.2%	no data
0.38%	Eversept Partners, L.P.	199,963	€1.3m	0%	0.1%
0.38%	Readystate Asset Management LP	199,358	€1.3m	0%	0.12%
0.37%	John Bailey	196,287	€1.3m	4.35%	no data
0.36%	STRS Ohio	192,700	€1.2m	0%	0.01%